PortfoliosLab logoPortfoliosLab logo
NBIS vs. AUTL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NBIS vs. AUTL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nebius Group N.V. (NBIS) and Autolus Therapeutics plc (AUTL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NBIS achieves a 160.44% return, which is significantly higher than AUTL's -26.63% return.


NBIS

1D
-4.31%
1M
23.13%
YTD
160.44%
6M
117.28%
1Y
351.53%
3Y*
5Y*
10Y*

AUTL

1D
-4.58%
1M
-7.01%
YTD
-26.63%
6M
-8.18%
1Y
-37.61%
3Y*
-20.17%
5Y*
-26.36%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NBIS vs. AUTL - Yearly Performance Comparison


2026 (YTD)20252024
NBIS
Nebius Group N.V.
160.44%202.18%46.25%
AUTL
Autolus Therapeutics plc
-26.63%-15.32%-50.00%

Correlation

The correlation between NBIS and AUTL is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Oct 18, 2024

0.23

Fundamentals

Market Cap

NBIS:

$67.36B

AUTL:

$388.57M

EPS

NBIS:

$3.17

AUTL:

-$1.09

PS Ratio

NBIS:

65.42

AUTL:

4.20

PB Ratio

NBIS:

9.30

AUTL:

3.57

Total Revenue (TTM)

NBIS:

$877.90M

AUTL:

$92.59M

Gross Profit (TTM)

NBIS:

$420.60M

AUTL:

-$10.36M

EBITDA (TTM)

NBIS:

-$52.78M

AUTL:

-$253.48M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NBIS vs. AUTL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIS
NBIS Risk / Return Rank: 9494
Overall Rank
NBIS Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
NBIS Sortino Ratio Rank: 9494
Sortino Ratio Rank
NBIS Omega Ratio Rank: 9090
Omega Ratio Rank
NBIS Calmar Ratio Rank: 9696
Calmar Ratio Rank
NBIS Martin Ratio Rank: 9595
Martin Ratio Rank

AUTL
AUTL Risk / Return Rank: 2222
Overall Rank
AUTL Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
AUTL Sortino Ratio Rank: 2323
Sortino Ratio Rank
AUTL Omega Ratio Rank: 2424
Omega Ratio Rank
AUTL Calmar Ratio Rank: 1616
Calmar Ratio Rank
AUTL Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBIS vs. AUTL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nebius Group N.V. (NBIS) and Autolus Therapeutics plc (AUTL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NBISAUTLDifference
Sharpe ratioReturn per unit of total volatility

+3.89

Sortino ratioReturn per unit of downside risk

+4.08

Omega ratioGain probability vs. loss probability

1.41

0.96

+0.45

Calmar ratioReturn relative to maximum drawdown

7.79

-0.69

+8.48

Martin ratioReturn relative to average drawdown

17.86

-0.96

+18.83

NBIS vs. AUTL - Sharpe Ratio Comparison

The current NBIS Sharpe Ratio is 3.39, which is higher than the AUTL Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of NBIS and AUTL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NBISAUTLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.39

-0.50

+3.89

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

3.19

-0.37

+3.56

Drawdowns

NBIS vs. AUTL - Drawdown Comparison

The maximum NBIS drawdown since its inception was -58.27%, smaller than the maximum AUTL drawdown of -97.63%. Use the drawdown chart below to compare losses from any high point for NBIS and AUTL.


Loading charts...

Drawdown Indicators


NBISAUTLDifference

Max Drawdown

Largest peak-to-trough decline

-58.27%

-97.63%

+39.36%

Max Drawdown (1Y)

Largest decline over 1 year

-45.47%

-54.85%

+9.38%

Max Drawdown (3Y)

Largest decline over 3 years

-84.36%

Max Drawdown (5Y)

Largest decline over 5 years

-85.68%

Current Drawdown

Current decline from peak

-17.58%

-96.96%

+79.38%

Average Drawdown

Average peak-to-trough decline

-19.02%

-81.27%

+62.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.79%

39.02%

-19.23%

Volatility

NBIS vs. AUTL - Volatility Comparison

Nebius Group N.V. (NBIS) has a higher volatility of 33.60% compared to Autolus Therapeutics plc (AUTL) at 24.19%. This indicates that NBIS's price experiences larger fluctuations and is considered to be riskier than AUTL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NBISAUTLDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.60%

24.19%

+9.41%

Volatility (6M)

Calculated over the trailing 6-month period

71.53%

52.08%

+19.45%

Volatility (1Y)

Calculated over the trailing 1-year period

104.78%

75.46%

+29.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

110.72%

77.73%

+32.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

110.72%

80.85%

+29.87%

Dividends

NBIS vs. AUTL - Dividend Comparison

Neither NBIS nor AUTL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NBIS vs. AUTL - Financials Comparison

This section allows you to compare key financial metrics between Nebius Group N.V. and Autolus Therapeutics plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
399.00M
26.22M
(NBIS) Total Revenue
(AUTL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NBIS and AUTL have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NBIS has higher volatility (33.60%) compared to AUTL (24.19%). In terms of maximum drawdown, NBIS dropped -58.27% vs AUTL's -97.63%.

NBIS currently has the higher Sharpe Ratio (3.39 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NBIS and AUTL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer